PAR 0.00% 23.5¢ paradigm biopharmaceuticals limited..

Video: Paradigm Biopharmaceuticals (ASX:PAR) conducting Phase 3 osteoarthritis trial, page-2

  1. 4,297 Posts.
    lightbulb Created with Sketch. 6826
    Thanks Dave,

    Nice video...Paul looked and presented well.

    Once we have the feedback from FDA...once we have P3 certainty and what the requirements are and once we have final launch approval...once we have TGA filed (and hopefully accepted!!)...
    ...we need to roadshow....we need so many new funds to look at us and invest in us...we need to buoy our stock.

    We need INTERNATIONAL exposure...great to have the locals start to take an interest..I want Global exposure...our drug is of this calibre.


    Blockbuster Market Opportunity?



    My thoughts
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
23.5¢
Change
0.000(0.00%)
Mkt cap ! $82.20M
Open High Low Value Volume
23.0¢ 23.5¢ 23.0¢ $74.06K 320.8K

Buyers (Bids)

No. Vol. Price($)
4 102830 23.0¢
 

Sellers (Offers)

Price($) Vol. No.
24.0¢ 703 1
View Market Depth
Last trade - 16.10pm 09/09/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.